NCT06247371Completed
Impact of a Novel Heart Failure Medication Decision Aid
Randomised Controlled Trial of a Heart Failure Medication Decision Aid in Singapore
Source: ClinicalTrials.gov · Last updated 11 Feb 2025
Brief summary (registry, in English)
A modified Zelen design randomised controlled trial over 6 months period is designed to investigate the influence of a heart failure medication decision aid prior to clinic session on shared decision making and its long term effect. Participants are randomised to either the decision aid arm or the usual care arm.
- Status (registry)
- Completed
- Study type
- Interventional
- Enrollment
- 150 (actual)
- First submitted
- 29 Jan 2024
- Start date
- 9 Apr 2024
- Primary completion date
- 25 Jul 2024
- Lead sponsor
- National University of Singapore
- Diseases
- Heart failure
- NCT number
- NCT06247371
What you commit to
- Study type: Interventional
- Participants enrolled: 150
- From 9 Apr 2024 to the primary completion date, 25 Jul 2024
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Patient is currently on Medifund OR have Medical Claims Pro-ration System (MCPS)
Age
- Age 21 years and below
Other
- Pregnant
- Incapable of personally giving consent
- Unable to speak and read English or Chinese
Who the study is looking for
- Diagnosed with heart failure with reduced ejection fraction (HFrEF)
- Singaporean nationality
Age in the registry: 22 years to - · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| NG Teng Fong General Hospital Coordinator of this site? Confirm its status | Singapore | Singapore | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.